4 completed, 4 recruiting, 2 unknown, 1 active not recruiting. 4 Not applicable, 4 Phase 2, 3 Phase 1, 1 Phase 3.
Follow Desmoid: new trials by email Literature Review of Desmoid trials Research Report on Desmoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRISM for Depression and Anxiety in Young Adults With Cancer Promoting Resilience in Stress Management Program - Cancer Diagnosis, Non-Metastatic Neoplasm | Not applicable | Completed | Dana-Farber Cancer Institute | 13 | 2024-09-06 | 2026-04-21 |
| A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors radiofrequency ablation - Desmoid Tumor, Desmoid Fibromatosis | Not applicable | Not yet recruiting | Blokhin's Russian Cancer Research Center | 27 | 2024-04-01 | 2024-04-10 |
| Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After Cryoablation Cryoablation - Desmoid | Recruiting | Istituto Ortopedico Rizzoli | 21 | 2024-02-20 | 2026-05-12 | |
| Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis Chemoembolization with Doxorubicin - Desmoid | Recruiting | Istituto Ortopedico Rizzoli | 20 | 2024-02-20 | 2026-05-14 | |
| FOG-001 in Locally Advanced or Metastatic Solid Tumors FOG-001, mFOLFOX-6, Nivolumab - Cancer, Colorectal Cancer | Phase 1 / Phase 2 | Recruiting | Parabilis Medicines, Inc. | 619 | 2023-05-23 | 2026-10-07 |
| Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor Anlotinib - Desmoid | Not applicable | Unknown | Henan Cancer Hospital | 30 | 2022-08-20 | 2023-10-30 |
| Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History. Pregnancy - Desmoid, Desmoid; Abdominal | Unknown | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 400 | 2022-03-01 | 2023-01-27 | |
| A Study of AL102 in Patients With Progressing Desmoid Tumors AL102, Placebo - Desmoid, Desmoid Tumor | Phase 2 / Phase 3 | Active not recruiting | Immunome, Inc. | 198 | 2021-09-01 | 2026-06-08 |
| Cryotherapy in the Treatment of Desmoid Tumors Cryotherapy - Desmoid | Not applicable | Recruiting | Istituto Ortopedico Rizzoli | 94 | 2021-05-20 | 2025-08-01 |
| Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis Drug Eluting Bead Embolization (DEB) for Desmoid Fibromatosis - Desmoid, Desmoid Fibromatosis of Skin | Phase 2 | Completed | Rabin Medical Center | 8 | 2018-10-11 | 2022-03-25 |
| Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma nab paclitaxel - Tumor, Desmoplastic Small Round Cell, Adult, Tumor, Desmoplastic Small Round Cell, Childhood | Phase 2 | Completed | Grupo Espanol de Investigacion en Sarcomas | 69 | 2017-05-09 | 2022-06-07 |
| HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors Doxorubicin HCl liposomal injection, Philips Sonalleve MR-HIFU Hyperthermia - Rhabdomyosarcoma, Neuroblastoma | Phase 1 | Withdrawn | Theodore Laetsch | 2016-12-01 | 2019-03-19 | |
| Endoxifen in Adults With Hormone Receptor Positive Solid Tumors Z-Endoxifen - Hormone Receptor-Positive Breast, Gynecologic | Phase 1 | Completed | National Cancer Institute (NCI) | 40 | 2011-03-01 | 2025-12-23 |
Desmoid Tumors (13) · Endometrial Neoplasms (2) · Neoplasms (2) · Sarcoma (2) · Sarcoma, Ewing (2) · Adenomatous Polyposis Coli (1) · Anxiety Disorders (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Colorectal Neoplasms (1) · Craniopharyngioma (1) · Depression (1) · Depressive Disorder (1) · Desmoid disease, hereditary (1) · Desmoplastic Small Round Cell Tumor (1)
Fibroma (13) · Neoplasms by Histologic Type (13) · Neoplasms, Connective Tissue (13) · Neoplasms, Connective and Soft Tissue (13) · Neoplasms, Fibrous Tissue (13) · Neoplasms (11) · Female Urogenital Diseases and Pregnancy Complications (3) · Urogenital Diseases (3) · Digestive System Diseases (2) · Female Urogenital Diseases (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasms by Site (2) · Neoplasms, Bone Tissue (2)
4-hydroxy-N-desmethyltamoxifen (1) · Albumin-Bound Paclitaxel (1) · Bevacizumab (1) · Cryosurgery (1) · Cryotherapy (1) · Doxorubicin (1) · Drug Therapy (1) · Fluorouracil (1) · Leucovorin (1) · Nivolumab (1) · Oxaliplatin (1) · Pregnancy (1) · Radiofrequency Ablation (1) · Taxes (1) · anlotinib (1)
Istituto Ortopedico Rizzoli (3) · Blokhin's Russian Cancer Research Center (1) · Dana-Farber Cancer Institute (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Grupo Espanol de Investigacion en Sarcomas (1) · Henan Cancer Hospital (1) · Immunome, Inc. (1) · National Cancer Institute (NCI) (1) · Parabilis Medicines, Inc. (1) · Rabin Medical Center (1) · Theodore Laetsch (1)
United States (6) · Italy (5) · Australia (2) · Israel (2) · Spain (2) · Belgium (1) · Canada (1) · China (1) · France (1) · Germany (1) · Netherlands (1) · Poland (1) · Russia (1) · South Korea (1) · United Kingdom (1)
Alice P Chen, M.D. (1) · Benjamin Oshrine (1) · Francisco Bautista, MD (1) · Greta J Khanna, PhD, MA (1) · Jaume Mora, MD (1) · Javier Martin Broto, MD (1) · Marco Fiore, MD (1) · Mrinal Gounder, MD (1) · Samantha Bento, PhD (1)
PMID 19768644, PMID 27064168, PMID 31236956, PMID 31401903, PMID 39956770
2016 (1)